NASDAQ
Antibe Therapeutics Inc. (ATBPF) has a current ratio of 15.03x as of Monday, May 25, 2026. This represents a 52.73% increase compared to its 12-month average of 9.84x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.